Cycloxan 50mg - Cyclophosphamide Tablets

Name: Cycloxan 50mg - Cyclophosphamide Tablets
Brand: NEXT GEN BIOTECH
Price: 500.0 INR
Availability: InStock

Price 500.0 INR/ Box

Get a Price/Quote

MOQ : 1 Box

Cycloxan 50mg - Cyclophosphamide Tablets Specification

Origin
India

Indication
Treatment of Lymphoma, Leukemia, Multiple Myeloma, Breast Cancer, and Ovarian Cancer

Dosage Form
Tablets

Salt Composition
Cyclophosphamide Tablets

Enzyme Types
Other

Feature
Other

Ingredients
Other

Application
Other

Ph Level
N/A

Temperature Needed For Fermentation
25 Celsius (oC)

Physical Color/Texture
Other

Fermentation Smell
Normal Smell

Enzymatic Activity
Alkylating Agent

Storage Instructions
Store below 25 C in a cool, dry place. Protect from moisture and direct sunlight.

Shelf Life
24 Months

Cycloxan 50mg - Cyclophosphamide Tablets Trade Information

Minimum Order Quantity
1 Box

FOB Port
Delhi

Payment Terms
Cash in Advance (CID), Cash Advance (CA)

Supply Ability
500 Boxes Per Month

Delivery Time
5 Days

Sample Available
No

Sample Policy
Contact us for information regarding our sample policy

Packaging Details
Box

Main Export Market(s)
Asia

Main Domestic Market
All India

Certifications
N/A

Cycloxan 50mg - Cyclophosphamide Tablets About

Cycloxan 50mg tablet is a chemotherapy drug containing the active constituent cyclophosphamide. It is used to treat various malignancies (abnormal production of cells is called cancer; if they spread, those are called malignancies). This tablet can be used to treat malignant lymphomas (cancers that start from the lymphatic system of the body- vessels, fluid, and lymphoid tissue) such as Hodgkins disease, lymphocytic lymphoma, and mixed-cell type lymphoma.

It treats leukemias, neuroblastoma, ovarian cancer, retinoblastoma, and breast carcinoma. It can also treat Minimal Change Nephrotic syndrome in pediatric patients (kidney disease in which large quantities of protein are lost in urine). Cycloxan 50mg tablet is contraindicated in pregnancy, patients with acute infections, urinary tract infections, urinary outflow obstruction, and bone marrow disorders.

Treatment with this medicine may lead to immune suppression, bone marrow failure, cardiotoxicity, renal toxicity, pulmonary toxicity, and secondary malignancies. Inform your doctor if you have pre-existing kidney disease, immune conditions, cardiac disorders, or liver diseases.